Newsletter

Fellows and young physicians gained practical experience in real anatomy during October's Practical Vascular Trainee Lab (PVTL), led by Kumar Madassery, MD, and supported by Reflow Medical’s dedicated education station.…

In Chicago, we proudly celebrated the U.S. launch of the Breakthrough Device, Spur Peripheral Retrievable Stent System, a milestone for Reflow Medical and BTK treatment. One highlight was our dedicated…

Spur® Peripheral Retrievable Stent System Receives FDA De NovoClearance We’re proud to announce that our first-of-its-kind Spur Stent System is now commercially available in the U.S. Featuring innovative Spur technology,…

Global PAD Assn. Recognizes Reflow Medical CEO Isa Rizk John Phillips, MD talks about raising PAD awareness with the winner of the “Corporate Champion of Awareness” Award, our own Isa…

Updates on Spur® Retrievable Scaffold Therapy (RST) at AMP At the Amputation Prevention Symposium (AMP) held in Chicago in August, S. Jay Mathews, MD, provided an excellent review: “Retrievable Stent…

Enrollment Completed in the DEEPER REVEAL Clinical Trial We want to thank everyone who worked to complete enrollment in the DEEPER REVEAL clinical trial (NCT05358353) to evaluate Spur™ Retrievable Scaffold…

CE Mark Certification for the Bare Temporary Spur Stent System Reflow has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System for…

  Expanding into Complex Percutaneous Coronary Interventions (PCI) with the introduction of the coraCatheters™ line We are proud to announce that we received FDA commercial clearance for our new coraCatheters…